publication venue for
- Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scale. 23:508-516. 2022
- Genetic testing for amyotrophic lateral sclerosis in Canada – an assessment of current practices. 23:305-312. 2022
- Author response to a Letter to the Editor entitled: Edaravone administration in pivotal clinical study 19 (Authors: Genge, Angela; Brooks, Benjamin). 20:300-302. 2019
- Is edaravone harmful? (A placebo is not a control). 19:477-482. 2018